AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)

Antiplatelet and anticoagulant drugs are classified antithrombotic agents with the purpose to reduce blood clot formation. For a successful treatment of many known complex cardiovascular diseases driven by platelet and/or coagulation activity, the need of more than one antithrombotic agent is inevit...

Descripción completa

Detalles Bibliográficos
Autores principales: Winzely, Maximilian, Jouppila, Annukka, Ramer, Georg, Lux, Laurin, Lendl, Bernhard, Barreiro, Karina, Lassila, Riitta, Friedbacher, Gernot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Paper in Forefront
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724117/
https://www.ncbi.nlm.nih.gov/pubmed/34773471
http://dx.doi.org/10.1007/s00216-021-03765-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724117/
https://www.ncbi.nlm.nih.gov/pubmed/34773471
http://dx.doi.org/10.1007/s00216-021-03765-y

Ejemplares similares